3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: June 3, 2010
Period of Report: June 1, 2010
Accession Number: 0001325812-10-000003

View Document ↗ View on SEC.gov ↗